BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 12660731)

  • 1. The role of PI3K in immune cells.
    Koyasu S
    Nat Immunol; 2003 Apr; 4(4):313-9. PubMed ID: 12660731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging and diverse roles of protein kinase C in immune cell signalling.
    Tan SL; Parker PJ
    Biochem J; 2003 Dec; 376(Pt 3):545-52. PubMed ID: 14570590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of phosphoinositide-3-kinase in mast cell homing to the gastrointestinal tract.
    Koyasu S; Minowa A; Terauchi Y; Kadowaki T; Matsuda S
    Novartis Found Symp; 2005; 271():152-61; discussion 161-5, 198-9. PubMed ID: 16605133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathophysiological roles of PI3Ks and therapeutic potential of selective inhibitors in allergic inflammation.
    Takeda M; Ito W; Tanabe M; Ueki S; Kihara J; Kato H; Tanigai T; Kayaba H; Sasaki T; Chihara J
    Int Arch Allergy Immunol; 2010; 152 Suppl 1():90-5. PubMed ID: 20523070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine tuning the immune response with PI3K.
    Fruman DA; Bismuth G
    Immunol Rev; 2009 Mar; 228(1):253-72. PubMed ID: 19290933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of class II phosphoinositide 3-kinase alpha expression below a critical threshold induces apoptotic cell death.
    Elis W; Triantafellow E; Wolters NM; Sian KR; Caponigro G; Borawski J; Gaither LA; Murphy LO; Finan PM; Mackeigan JP
    Mol Cancer Res; 2008 Apr; 6(4):614-23. PubMed ID: 18403640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-lymphocyte navigation and migration: beyond the PI3K paradigm.
    Smith L; Webb A; Ward SG
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):193-8. PubMed ID: 17371236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacteria directly induce cytoskeletal rearrangements for macrophage spreading and polarization through TLR2-dependent PI3K signaling.
    Lasunskaia EB; Campos MN; de Andrade MR; Damatta RA; Kipnis TL; Einicker-Lamas M; Da Silva WD
    J Leukoc Biol; 2006 Dec; 80(6):1480-90. PubMed ID: 17005905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PI3 kinases in cancer: from oncogene artifact to leading cancer target.
    Zhao JJ; Roberts TM
    Sci STKE; 2006 Dec; 2006(365):pe52. PubMed ID: 17164467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of EGF receptor transactivation in phosphoinositide 3-kinase-dependent activation of MAP kinase by GPCRs.
    Shah BH; Neithardt A; Chu DB; Shah FB; Catt KJ
    J Cell Physiol; 2006 Jan; 206(1):47-57. PubMed ID: 15920762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of class II phosphoinositide 3-kinase in cell signalling.
    Falasca M; Maffucci T
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):211-4. PubMed ID: 17371240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive visualization of the lipid product of class I PI3K in transgenic mouse models.
    Sasaki T; Sasaki J; Watanabe K; Suzuki A
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):215-8. PubMed ID: 17371241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications.
    Weichhart T; Säemann MD
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii70-4. PubMed ID: 19022819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond?
    Rommel C; Camps M; Ji H
    Nat Rev Immunol; 2007 Mar; 7(3):191-201. PubMed ID: 17290298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of the alpha-isoform of class II phosphoinositide 3-kinase gene expression leads to apoptotic cell death.
    Kang S; Song J; Kang J; Kang H; Lee D; Lee Y; Park D
    Biochem Biophys Res Commun; 2005 Apr; 329(1):6-10. PubMed ID: 15721265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective dendritic cell migration and activation of adaptive immunity in PI3Kgamma-deficient mice.
    Del Prete A; Vermi W; Dander E; Otero K; Barberis L; Luini W; Bernasconi S; Sironi M; Santoro A; Garlanda C; Facchetti F; Wymann MP; Vecchi A; Hirsch E; Mantovani A; Sozzani S
    EMBO J; 2004 Sep; 23(17):3505-15. PubMed ID: 15318168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of class IA PI3Ks: is there a role for monomeric PI3K subunits?
    Geering B; Cutillas PR; Vanhaesebroeck B
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):199-203. PubMed ID: 17371237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct functions of H-Ras and K-Ras in proliferation and survival of primary hepatocytes due to selective activation of ERK and PI3K.
    Rosseland CM; Wierød L; Flinder LI; Oksvold MP; Skarpen E; Huitfeldt HS
    J Cell Physiol; 2008 Jun; 215(3):818-26. PubMed ID: 18163378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreases in phosphoinositide-3-kinase/Akt and extracellular signal-regulated kinase 1/2 signaling activate components of spinal motoneuron death.
    Newbern J; Taylor A; Robinson M; Li L; Milligan CE
    J Neurochem; 2005 Sep; 94(6):1652-65. PubMed ID: 16045454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the catalytic subunit of class IA PI3K confer leukemogenic potential to hematopoietic cells.
    Horn S; Bergholz U; Jücker M; McCubrey JA; Trümper L; Stocking C; Bäsecke J
    Oncogene; 2008 Jul; 27(29):4096-106. PubMed ID: 18317450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.